Veracyte: UBS cuts target price to $35 from $65
VCYT•UBS cut its target price for Veracyte to $35 from $65.
Related News
KKR reportedly seeks investor in power firm ContourGlobal at £4 billion value
KKR•
Greenland Mines raises AnorTech stake to 19.9% through share exchange
GRML•
Advanced Micro Devices 5th Gen EPYC CPUs power Google Cloud TPU 8tx with confidential computing
AMD•
PNC to offer stablecoin payments to clients in Coinbase partnership
COIN•
Avient partners with Albert Invent to deploy AI across global R&D network
AVNT•